October 26, 2017
By Sarah Harris-Steingrüber
A recent report from the United Nations Special Rapporteur on the Right to Health has explicitly highlighted that corruption in the health sector is a key barrier to achieving the 2030 agenda, as well as having a devastating impact on an international, national and local level. This supports the long-held view of Transparency International’s Pharmaceuticals and Healthcare Programme (TI-PHP) that corruption in the health sector is very much a matter of life and death.
The report makes a number of specific recommendations to states, urging them to address corruption through multiple ways, all of which TI-PHP strongly agree with. These include calling on states to:
The attention of the UN to this issue is a welcome step and it remains crucial that the human rights community commit their attention to corruption, particularly as it undermines the achievement of the highest attainable standard of health – a fundamental right of every human being. While this is a global concern, corruption in health affects certain populations more seriously than others, perpetuates global inequalities and hinders sustainable global development.
Meanwhile, we in TI-PHP are continually committed to guaranteeing the human right to health by achieving genuine change in the health sector through reducing corruption and promoting transparency, integrity and accountability. We bring a coordinated international response that mobilises government and local communities, and constructively engages all the key players including the public sector, the private sector, global institutions and civil society.
Across our Movement, Transparency International is fighting corruption in the healthcare sector as called for in the Special rapporteur’s report.
Some examples of this work include:
Every day, all around the world, people suffer and die due to corruption in the pharmaceutical and healthcare sectors. Building on the results of the Special Rapporteur’s report, TI PHP invites global stakeholders to join us in our efforts to create a sustainable future that guarantees everyone’s right to health.
About Sarah Harris-Steingrüber
Sarah joined the Pharmaceuticals & Healthcare Programme in January 2017 and has a strong background in the area of public health and international development and has worked with UN and national development agencies in Europe, Southeast Asia and West Africa.